Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Global market forecast of oncologics and supportive care biosimilars 2020

Global market forecast for oncologics and supportive care biosimilars in 2015 and 2020 (in billion U.S. dollars)

by Statista Research Department, last edited May 22, 2014
Global market forecast of oncologics and supportive care biosimilars 2020 This statistic displays a global market forecast for oncology products and supportive care biosimilars in 2015 and 2020. By 2020, the global market is expected to reach between 6 and 12 billion U.S. dollars.
Cancer drug market

A forecast for global oncologics and supportive care biosimilars expects that the market will reach a minimum of 6 billion U.S. dollars and a maximum of 12 billon U.S. dollars in 2020. Biosimilars used for cancer treatment and supportive care will likely enter the U.S. market in the near future. These drugs will be very similar to their branded products but differences may exist due to complexities and differences in manufacturing processes. Maintaining a rigorous safety monitoring of biosimilars will be important in tracking its effectiveness and any potential consequences.

The number of cancer drugs being developed has increased over the last few years, increasing from 399 drugs in 2005 to 981 drugs in 2012. As of 2013, Rituxan/MabThera marketed by Roche was one of the top selling oncologic pharmaceutical drugs globally, reaching a revenue of 7.78 billion U.S. dollars. Roche also produces other top cancer drugs like Avastin and Herceptin which have reached revenues of 6.75 billion U.S. dollars and 6.56 billion U.S. dollars, respectively, during this year. Rituximab primarily destroy B cells which tend to be overly produced or dysfunctional in lymphomas, leukemias, autoimmune disorders, and in transplant rejections. The U.S. patent will expire in 2015 and will likely alter the market for this drug.
Show more

Global market forecast for oncologics and supportive care biosimilars in 2015 and 2020 (in billion U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Oncology"
  • Cancer facts
The most important statistics
  • Oncology market
  • Companies
  • Cancer drugs
  • Research and development
  • Immuno-oncology
  • Treatment types
  • Physicians and patients
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.